The project will be based at one of the country’s leading universities, Monash, and will produce 100 million doses of vaccine per year, against Covid-19, influenza and other diseases.
Article written by
Published
Update
Reading time : 1 min.
The Moderna laboratory announced on Monday August 15 the opening of a messenger RNA vaccine factory in Melbourne, Australia, a first in the southern hemisphere. The project will be based at one of the country’s leading universities, Monash, and will produce 100 million doses of vaccine per year, against Covid-19, influenza and other diseases.
Moderna’s Spikevax for the coronavirus was among the first vaccines to use new technology called messenger RNA developed during the Covid-19 pandemic.
These vaccines, which can be developed quickly, use a molecule to teach the body how to identify and fight a pathogen, such as the coronavirus, unlike traditional vaccines, which contain a small piece of bacteria or virus. Construction of the Moderna factory is due to begin this year and be completed in 2024.